Expression and function of collagens in intrahepatic cholangiocarcinoma

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is an aggressive malignancy that originates from the biliary tract located within the liver parenchyma. While the incidence rate of iCCA is increasing worldwide, the existing therapeutic options still remain limited. Thus, the spread of iCCA is the foremost cause of treatment failure representing a major clinical challenge. The aggressive nature and refractoriness of the iCCA are strictly related to the desmoplastic tumor microenvironment, in which cancer cells are surrounded by inflammatory cells, cancer-associated fibroblasts, and the aberrant deposition of members of the collagen family. In recent years, accumulating evidence revealed that remodeling of collagens is pivotal in driving the dissemination of desmoplastic cancers. In this review, we describe the expression profile of collagens and their unique architecture in iCCA and how this can dictate neoplastic cell behavior. The emerging view argues for specific strategies aimed at targeting the collagen architecture that may be useful to hamper iCCA metastasis.

Keywords

Intrahepatic cholangiocarcinoma / tumor microenvironment / extracellular matrix / collagen / lymphangiogenesis

References

[1] Banales JM,Lamarca A.Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Nat Rev Gastroenterol Hepatol2020;17:557-88 PMCID:PMC7447603

[2] Bertuccio P,Carioli G.Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.J Hepatol2019;71:104-14

[3] Jutric Z,Hoen HM.Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.HPB2016;18:79-87 PMCID:PMC4750232

[4] Cadamuro M,Guido M.Translational value of tumor-associated lymphangiogenesis in cholangiocarcinoma.J Pers Med2022;12:1086 PMCID:PMC9324584

[5] Kodali S,Ghobrial RM.Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?.Curr Opin Organ Transplant2022;27:320-8

[6] Aliseda D,Zozaya G.Liver resection and transplantation following yttrium-90 radioembolization for primary malignant liver tumors: a 15-year single-center experience.Cancers2023;15:733 PMCID:PMC9913597

[7] Brivio S,Strazzabosco M.Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness.World J Hepatol2017;9:455-68 PMCID:PMC5368623

[8] Sirica AE.Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Hepatology2014;59:2397-402 PMCID:PMC3975806

[9] Carpino G,Melandro F.Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure.Clin Proteomics2019;16:37 PMCID:PMC6821022

[10] Cadamuro M,Mertens J.Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.J Hepatol2019;70:700-9

[11] Carpino G,Di Giamberardino A.Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.J Hepatol2021;75:1377-86

[12] Cadamuro M,Zhang X.Tumor microenvironment and immunology of cholangiocarcinoma.HR2022;8:11

[13] Sirica AE.The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.Nat Rev Gastroenterol Hepatol2011;9:44-54

[14] Okabe H,Hayashi H.Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.Ann Surg Oncol2009;16:2555-64

[15] Dranoff JA.Portal fibroblasts: underappreciated mediators of biliary fibrosis.Hepatology2010;51:1438-44 PMCID:PMC2850946

[16] Quante M,Tomita H.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.Cancer Cell2011;19:257-72 PMCID:PMC3060401

[17] Cadamuro M,Indraccolo S.Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Hepatology2013;58:1042-53 PMCID:PMC3732815

[18] da Cunha BR,Stefanini ACB.Cellular interactions in the tumor microenvironment: the role of secretome.J Cancer2019;10:4574-87 PMCID:PMC6746126

[19] Fabris L,Mertens J.The tumour microenvironment and immune milieu of cholangiocarcinoma.Liver Int2019;39 Suppl 1:63-78

[20] Sulpice L,Desille M.Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.Hepatology2013;58:1992-2000

[21] Sirica AE,Li C.Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.Exp Mol Pathol2014;97:515-24 PMCID:PMC4262539

[22] Sirica AE. Matricellular proteins in intrahepatic cholangiocarcinoma. hepatobiliary cancers: translational advances and molecular medicine. Elsevier; 2022. pp. 249-81.

[23] Lu P,Werb Z.The extracellular matrix: a dynamic niche in cancer progression.J Cell Biol2012;196:395-406 PMCID:PMC3283993

[24] Mohan V,Sagi I.Emerging roles of ECM remodeling processes in cancer.Semin Cancer Biol2020;62:192-200

[25] Frantz C,Weaver VM.The extracellular matrix at a glance.J Cell Sci2010;123:4195-200 PMCID:PMC2995612

[26] Theocharis AD,Gialeli C.Extracellular matrix structure.Adv Drug Deliv Rev2016;97:4-27

[27] Shoulders MD.Collagen structure and stability.Annu Rev Biochem2009;78:929-58 PMCID:PMC2846778

[28] Bonnans C,Werb Z.Remodelling the extracellular matrix in development and disease.Nat Rev Mol Cell Biol2014;15:786-801 PMCID:PMC4316204

[29] Levental KR,Kass L.Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell2009;139:891-906 PMCID:PMC2788004

[30] Maller O,Barrett AS.Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression.Nat Mater2021;20:548-59 PMCID:PMC8005404

[31] Al-Zuhair AG,Al-Bader AA.Expression of connective tissue stromal elements in human cholangiocarcinomas. an immunohistochemical and ultrastructural study.J Submicrosc Cytol1987;19:321-7.

[32] Arteel GE.The liver matrisome - looking beyond collagens.JHEP Rep2020;2:100115 PMCID:PMC7330160

[33] Lai KK,Lohia N.Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models.PLoS Genet2011;7:e1002147 PMCID:PMC3121762

[34] Gelse K,Aigner T.Collagens--structure, function, and biosynthesis.Adv Drug Deliv Rev2003;55:1531-46

[35] Exposito JY,Cluzel C.The fibrillar collagen family.Int J Mol Sci2010;11:407-26 PMCID:PMC2852846

[36] Okamura N,Shibuya A.Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.Pathol Int2005;55:724-31

[37] Linsenmayer TF,Igoe F.Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis.J Cell Biol1993;121:1181-9 PMCID:PMC2119697

[38] Von Der Mark K. Structure, biosynthesis and gene regulation of collagens in cartilage and bone. dynamics of bone and cartilage metabolism. Elsevier; 2006. pp. 3-40.

[39] Yu X,Li Q.Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro.Tumour Biol2014;35:3103-12

[40] Mak KM.Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease.Anat Rec2017;300:1371-90

[41] Terada T.Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.Histopathology1994;25:143-50

[42] Brivio S,Fabris L.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Gene Expr2018;18:31-50 PMCID:PMC5860940

[43] Cescon M,Chen P.Collagen VI at a glance.J Cell Sci2015;128:3525-31

[44] Keene DR,Glanville RW.Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network.J Cell Biol1988;107:1995-2006 PMCID:PMC2115316

[45] Takahara T,Muona P.Type VI collagen gene expression in experimental liver fibrosis: quantitation and spatial distribution of mRNAs, and immunodetection of the protein.Liver1995;15:78-86

[46] Baiocchini A,Conigliaro A.Extracellular matrix molecular remodeling in human liver fibrosis evolution.PLoS One2016;11:e0151736 PMCID:PMC4801190

[47] Chen P,Bonaldo P.Collagen VI in cancer and its biological mechanisms.Trends Mol Med2013;19:410-7

[48] Trueb B.Loss of type VI collagen in experimental and most spontaneous human fibrosarcomas.Int J Cancer2000;86:331-6

[49] Izzi V,Heikkinen A,Koivunen J.Exploring the roles of MACIT and multiplexin collagens in stem cells and cancer.Semin Cancer Biol2020;62:134-48

[50] Abdollahi A,Maercker C.Endostatin’s antiangiogenic signaling network.Mol Cell2004;13:649-63

[51] Musso O,Heljasvaara R.Tumor hepatocytes and basement membrane-Producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers.Hepatology2001;33:868-76

[52] Saarela J,Rehn M,Pihlajaniemi T.Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts.Matrix Biol1998;16:319-28

[53] Cox TR,Baker AM.LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis.Cancer Res2013;73:1721-32 PMCID:PMC3672851

[54] Lin HY,Yang YL.Roles of lysyl oxidase family members in the tumor microenvironment and progression of liver cancer.Int J Mol Sci2020;21:9751 PMCID:PMC7766343

[55] Bergeat D,Turlin B.Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.J Surg Res2016;203:441-50

[56] Vihinen P.Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.Int J Cancer2002;99:157-66

[57] Terada T,Nakanuma Y.Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.Hepatology1996;23:1341-4

[58] Jones CE,Colbert SE.Pten regulates collagen fibrillogenesis by fibroblasts through SPARC.PLoS One2021;16:e0245653 PMCID:PMC7857610

[59] Deng S,Li J,Wang J.Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.Tissue Cell2022;76:101756

[60] Sonongbua J,Thongchot S.Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma.Oncol Rep2020;43:1147-58 PMCID:PMC7057947

[61] Provenzano PP,Campbell JM.Collagen reorganization at the tumor-stromal interface facilitates local invasion.BMC Med2006;4:38 PMCID:PMC1781458

[62] Ray A,Morford RK,Provenzano PP.Enhanced directional migration of cancer stem cells in 3D aligned collagen matrices.Biophys J2017;112:1023-36 PMCID:PMC5355487

[63] Huang Y.Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue.Scanning2014;36:334-7

[64] Drifka CR,Mathewson K.Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.Oncotarget2016;7:76197-213 PMCID:PMC5342807

[65] Deng B,Kong W,Shen X.Biological role of matrix stiffness in tumor growth and treatment.J Transl Med2022;20:540 PMCID:PMC9682678

[66] Keikhosravi A,Conklin MW.Real-time polarization microscopy of fibrillar collagen in histopathology.Sci Rep2021;11:19063 PMCID:PMC8463693

[67] Shi R,Zhu A.Targeting type I collagen for cancer treatment.Int J Cancer2022;151:665-83

[68] Baldari S,Nisticò P.Strategies for efficient targeting of tumor collagen for cancer therapy.cancers2022;14:4706 PMCID:PMC9563908

[69] Liang H,Wang B.A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix.Sci Rep2016;6:18205 PMCID:PMC4756367

[70] Momin N,Bennett NR.Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy.Sci Transl Med2019;11 PMCID:PMC7811803

[71] Smithen DA,Challinor M.2-Aminomethylene-5-sulfonylthiazole inhibitors of lysyl oxidase (LOX) and LOXL2 show significant efficacy in delaying tumor growth.J Med Chem2020;63:2308-24 PMCID:PMC7073924

[72] Liu YL,Willumsen N.Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.NPJ Breast Cancer2021;7:108 PMCID:PMC8382701

[73] Peng T,Tian F.The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.Int J Oncol2019;55:657-70 PMCID:PMC6685595

[74] McGaha TL,Spiera H.Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.J Invest Dermatol2002;118:461-70

[75] Cortes E,Rice A.Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor.Oncogene2019;38:2910-22 PMCID:PMC6755965

[76] Nicolas-Boluda A,Vimeux L.Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021;10 PMCID:PMC8203293

[77] Ortona E,Delunardo F,Giovannetti A.Relationship between redox status and cell fate in immunity and autoimmunity.Antioxid Redox Signal2014;21:103-22

[78] Su B,Shi B.Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.Mol Cancer2014;13:206 PMCID:PMC4168121

[79] Yu J,Zhang H.E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.Biochem Biophys Res Commun2019;512:150-5